UnitedHealth Group Inc (UNH) Shares Bought by Ballentine Partners LLC
Ballentine Partners LLC lifted its position in UnitedHealth Group Inc (NYSE:UNH) by 2.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 11,711 shares of the healthcare conglomerate’s stock after purchasing an additional 237 shares during the quarter. Ballentine Partners LLC’s holdings in UnitedHealth Group were worth $2,294,000 at the end of the most recent quarter.
Several other institutional investors have also recently added to or reduced their stakes in the company. Sei Investments Co. increased its stake in UnitedHealth Group by 12.9% in the third quarter. Sei Investments Co. now owns 705,959 shares of the healthcare conglomerate’s stock valued at $138,262,000 after acquiring an additional 80,588 shares during the last quarter. HL Financial Services LLC increased its stake in UnitedHealth Group by 18.1% in the third quarter. HL Financial Services LLC now owns 16,201 shares of the healthcare conglomerate’s stock valued at $3,173,000 after acquiring an additional 2,482 shares during the last quarter. Suffolk Capital Management LLC increased its stake in UnitedHealth Group by 14.5% in the third quarter. Suffolk Capital Management LLC now owns 59,187 shares of the healthcare conglomerate’s stock valued at $11,592,000 after acquiring an additional 7,491 shares during the last quarter. FDx Advisors Inc. increased its stake in UnitedHealth Group by 11.5% in the third quarter. FDx Advisors Inc. now owns 52,491 shares of the healthcare conglomerate’s stock valued at $10,280,000 after acquiring an additional 5,431 shares during the last quarter. Finally, Jennison Associates LLC increased its stake in UnitedHealth Group by 146.0% in the third quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock valued at $1,085,396,000 after acquiring an additional 3,289,470 shares during the last quarter. 86.01% of the stock is currently owned by hedge funds and other institutional investors.
Shares of UnitedHealth Group Inc (UNH) opened at $225.88 on Wednesday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70. UnitedHealth Group Inc has a 1 year low of $156.09 and a 1 year high of $231.77. The stock has a market cap of $218,390.00, a PE ratio of 25.67, a price-to-earnings-growth ratio of 1.57 and a beta of 0.66.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The business had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. During the same period in the prior year, the business posted $2.17 earnings per share. The company’s revenue was up 8.7% on a year-over-year basis. equities research analysts anticipate that UnitedHealth Group Inc will post 9.99 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st were issued a dividend of $0.75 per share. The ex-dividend date was Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.33%. UnitedHealth Group’s dividend payout ratio is currently 34.09%.
A number of research firms recently commented on UNH. Jefferies Group reissued a “buy” rating and issued a $248.00 target price on shares of UnitedHealth Group in a research note on Friday, December 1st. Leerink Swann reissued an “outperform” rating on shares of UnitedHealth Group in a research note on Friday, December 1st. Sanford C. Bernstein increased their target price on UnitedHealth Group from $219.00 to $246.00 and gave the company an “outperform” rating in a research note on Friday, December 1st. Goldman Sachs Group began coverage on UnitedHealth Group in a research note on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 target price on the stock. Finally, Cantor Fitzgerald reissued a “buy” rating and issued a $235.00 target price on shares of UnitedHealth Group in a research note on Monday, December 25th. Three equities research analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the company. UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $226.74.
In other news, CEO Larry C. Renfro sold 22,598 shares of the stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the completion of the sale, the chief executive officer now directly owns 195,314 shares in the company, valued at $43,310,879.50. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of the stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the sale, the director now owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 34,630 shares of company stock valued at $7,669,416. 0.89% of the stock is currently owned by company insiders.
COPYRIGHT VIOLATION NOTICE: “UnitedHealth Group Inc (UNH) Shares Bought by Ballentine Partners LLC” was originally posted by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another website, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this news story can be accessed at https://www.watchlistnews.com/unitedhealth-group-inc-unh-shares-bought-by-ballentine-partners-llc/1801015.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with Analyst Ratings Network's FREE daily email newsletter.